Inventor · disambiguated record
Stefan Lehner
Also filed as: LEHNER STEFAN · LEHNER STEFAN JOHANNES
12 granted patents·4 pending applications·32 citations·filing 2007–2024
88Inventor score
Top patents by PatentIndex Score
16 records- 0183US8741350B2Taste masked pharmaceutical compositionFOLGER MARTIN·Filed 2012·Granted Jun 3, 2014·10 cites·40 claims
- 0280US8871795B2Pharmaceutical oral telmisartan solutionMOHR DETLEF·Filed 2010·Granted Oct 28, 2014·7 cites·16 claims
- 0377US9795568B2Low concentration meloxicam tabletsFOLGER MARTIN A·Filed 2011·Granted Oct 24, 2017·1 cites·19 claims
- 0476US9943486B2Low concentration meloxicam tabletsFOLGER MARTIN A·Filed 2013·Granted Apr 17, 2018·1 cites·25 claims
- 0576US9289390B2Taste masked pharmaceutical compositionFOLGER MARTIN·Filed 2014·Granted Mar 22, 2016·5 cites·9 claims
- 0675US9107952B2Liquid preparation comprising pimobendanFOLGER MARTIN·Filed 2007·Granted Aug 18, 2015·2 cites·18 claims
- 0774US10639305B2Liquid preparation comprising pimobendanBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2017·Granted May 5, 2020·1 cites·13 claims
- 0874US10537523B2Oral suspension comprising telmisartanBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2019·Granted Jan 21, 2020·1 cites·12 claims
- 0973US10905676B2Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in catsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2018·Granted Feb 2, 2021·1 cites·8 claims
- 1071US10314782B2Oral suspension comprising telmisartanMOHR DETLEF·Filed 2014·Granted Jun 11, 2019·2 cites·11 claims
- 1170US9616134B2Liquid preparation comprising pimobendanFOLGER MARTIN·Filed 2014·Granted Apr 11, 2017·1 cites·12 claims
- 1266US10278924B2Low concentration meloxicam tabletsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2017·Granted May 7, 2019·0 cites·17 claims
- 1362US2024307628A1Systems and methods for delivery of liquid pharmaceutical compositions in particular comprising one or more sglt-2 inhibitor(s)BOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2024·Application pending·0 cites
- 1456US2021106564A1Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in catsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2020·Application pending·0 cites
- 1549US2024062131A1Data Driven Multi-Criteria Optimization of Chemical FormulationsBASF SE·Filed 2021·Application pending·0 cites
- 1643US2014224680A1Kit-of-partsFOLGER MARTIN·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefan Lehner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →